The plants in Covington and Madison, Ga., both southeast of Atlanta, use ethylene oxide (EO) to sterilize medical devices. The federal Environmental Protection Agency recognizes EO as a carcinogen and lowered its limits on emissions of the sterilant gas in 2016. BD acquired the plants when it bought C.R. Bard in 2017.
Home » BD to spend $8m to cut EO emissions in Georgia
In case you missed it
- Danaher dental spinout Envista closes $677m IPO
- Cantel Medical beats expectations for fiscal Q4, 2019
- EU Commission lays out plan on expert panels under MDR, IVDR
- Access Vascular logs GPO win with Premier contract
- FDA joins ‘collaborative communities’
- TAVR technique cuts pacemaker implantation rate
- Ambrosia app links Abbott’s FreeStyle Libre with Fitbit wearable
- How can medical device companies thrive in the future?
- Synchron touts first-in-human implantation for brain-computer interface
- Balt parent escapes Neurvana Medical sabotage suit
- FDA IDs first devices for expedited 510(k) clearance review
- Zimmer Biomet, Align Technology ink distribution deal
- Report: Medtronic plans 100 more layoffs in shift from California to Massachusetts
- Integra Lifesciences touts Cadence ankle study
- Active Implants wins breakthrough nod for NUsurface knee implant
- Key questions for medical device companies to tackle gaps in cybersecurity processes
- Where are the world’s medtech headquarters?